Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines

The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era

(2012) Marylyn D. Ritchie   HUMAN GENETICS

A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT

(2012) Chad C. Brown et al.   Pharmacogenetics and Genomics

Multivariate methods and software for association mapping in dose‐response genome‐wide association studies

(2012) Chad C Brown et al.   BioData Mining

Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy

(2011) X.-L. Tan et al.   CLINICAL CANCER RESEARCH

Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets

(2011) Miao-Xin Li et al.   HUMAN GENETICS

Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic

(2011) Jacob E. Shabason et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Genomic Profiling in CEPH Cell Lines Distinguishes between the Camptothecins and Indenoisoquinolines

(2011) V. G. Watson et al.   MOLECULAR CANCER THERAPEUTICS

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

(2011) Eric J Peters et al.   PHARMACOGENOMICS

Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation

(2011) Heather E Wheeler et al.   PHARMACOGENOMICS

Identification and Replication of Loci Involved in Camptothecin-Induced Cytotoxicity Using CEPH Pedigrees

(2011) Venita Gresham Watson et al.   PLoS One

Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers

(2011) Dana Ziliak et al.   Translational Research

A comparison of association methods for cytotoxicity mapping in pharmacogenomics

(2011) Chad Brown   Frontiers in Genetics

Quality control and quality assurance in genotypic data for genome-wide association studies

(2010) Cathy C. Laurie et al.   GENETIC EPIDEMIOLOGY

Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines

(2010) A L Stark et al.   PHARMACOGENOMICS JOURNAL

Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations

(2010) Mathew J. Barber et al.   PLoS One

Genotype Imputation

(2009) Yun Li et al.   Annual Review of Genomics and Human Genetics

Pharmacogenomic Discovery Using Cell-Based Models

(2009) M. Welsh et al.   PHARMACOLOGICAL REVIEWS

Gemcitabine and Cytosine Arabinoside Cytotoxicity: Association with Lymphoblastoid Cell Expression

(2008) L. Li et al.   CANCER RESEARCH

Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin

(2008) Marisa Wong Medina et al.   CIRCULATION

Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans

(2008) R. S. Huang et al.   MOLECULAR CANCER THERAPEUTICS

Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines

(2008) Edwin Choy et al.   PLoS Genetics